Shi-Fang Yan

1.8k citations
10 papers · 1.6k indexed · h-index 10
Topics
Cancer, Hypoxia, and Metabolism (5 papers)Nitric Oxide and Endothelin Effects (2 papers)Immune Response and Inflammation (2 papers)
Partner nations
United StatesGermany

In The Last Decade

Shi-Fang Yan

10 papers receiving 1.5k citations

Peers

Shi-Fang Yan
Comparison fields: 5 of 98
  • Molecular Biology 731
  • Cancer Research 371
  • Immunology 332
  • Surgery 180
  • Physiology 162
Replace Sucharita SenBanerjee with:
Sucharita SenBanerjee United States
Guadalupe Ortiz-Muñoz Spain
Zhiyong Lin United States
Elke Müller Germany
Andrea L. True United States
K. Satoh Japan
Carla Jennewein Germany
Mark D. Rekhter United States
Hirotaka Isobe Japan
Anke Doller Germany
Shi-Fang Yan relative to Sucharita SenBanerjee United States Sucharita SenBanerjee's profile →
Citations per field
00.5×1.5×
Sucharita SenBanerjee · 1×
Citations per year

Countries citing papers authored by Shi-Fang Yan

Since Specialization
Citations

This map shows the geographic impact of Shi-Fang Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi-Fang Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi-Fang Yan more than expected).

Fields of papers citing papers by Shi-Fang Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shi-Fang Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi-Fang Yan. The network helps show where Shi-Fang Yan may publish in the future.

Co-authorship network of co-authors of Shi-Fang Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Shi-Fang Yan. A scholar is included among the top collaborators of Shi-Fang Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shi-Fang Yan. Shi-Fang Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 54
2 35
3 125
4 330
5 405
6 45
7 41
8 217
9 149
10 159

About Shi-Fang Yan

Shi-Fang Yan is a scholar working on Cancer Research, Internal Medicine and Physiology, having authored 10 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (5 papers), Nitric Oxide and Endothelin Effects (2 papers) and Immune Response and Inflammation (2 papers). The work is most often cited by research in Cancer Research (371 citations), Internal Medicine (81 citations) and Immunology (332 citations). Shi-Fang Yan has collaborated with scholars based in United States and Germany. Frequent co-authors include David M. Stern, Nigel Mackman, David J. Pinsky, Jiesheng Lu, Yu Zou, Tomoyuki Fujita, Walter Kisiel, Yu Zou, Kenji Okada and Maria A. O’Connell. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026